| Anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0009 events9 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG00212 events12 affected6,988 at risk
|
| Anaemia macrocytic | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anaemia megaloblastic | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anaemia of chronic disease | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anaemia of malignant disease | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0027 events2 affected6,988 at risk
|
| Anaemia vitamin B12 deficiency | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Aplastic anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Coagulation factor deficiency | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Coagulopathy | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Febrile neutropenia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Haemolysis | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Heparin-induced thrombocytopenia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypercoagulation | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypochromic anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Immune thrombocytopenic purpura | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Increased tendency to bruise | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG00111 events11 affected6,958 at risk
- EG00225 events24 affected6,988 at risk
|
| Leukocytosis | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Leukopenia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Lymphadenopathy | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Nephrogenic anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Normochromic normocytic anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Pancytopenia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Pernicious anaemia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Splenic haemorrhage | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Splenomegaly | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Spontaneous haematoma | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Spontaneous haemorrhage | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0028 events8 affected6,988 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Acute left ventricular failure | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events5 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00028 events28 affected6,996 at risk
- EG00120 events20 affected6,958 at risk
- EG00219 events19 affected6,988 at risk
|
| Adams-Stokes syndrome | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00053 events51 affected6,996 at risk
- EG00147 events45 affected6,958 at risk
- EG00255 events51 affected6,988 at risk
|
| Angina unstable | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Aortic valve disease | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Aortic valve stenosis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Arrhythmia supraventricular | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Arteriosclerosis coronary artery | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00073 events67 affected6,996 at risk
- EG001104 events94 affected6,958 at risk
- EG00288 events74 affected6,988 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00020 events16 affected6,996 at risk
- EG00115 events14 affected6,958 at risk
- EG00213 events13 affected6,988 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Atrial thrombosis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Atrioventricular block | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Atrioventricular block complete | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00014 events13 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Atrioventricular block second degree | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Bifascicular block | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bradyarrhythmia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Bradycardia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Bundle branch block left | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bundle branch block right | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cardiac arrest | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG0028 events7 affected6,988 at risk
|
| Cardiac asthma | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00073 events58 affected6,996 at risk
- EG00170 events53 affected6,958 at risk
- EG00269 events54 affected6,988 at risk
|
| Cardiac failure acute | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Cardiac failure chronic | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00016 events14 affected6,996 at risk
- EG00119 events11 affected6,958 at risk
- EG00225 events19 affected6,988 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00060 events51 affected6,996 at risk
- EG00179 events53 affected6,958 at risk
- EG00297 events70 affected6,988 at risk
|
| Cardiac hypertrophy | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cardiac perforation | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cardiac tamponade | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cardiac valve disease | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cardiac ventricular thrombosis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0027 events6 affected6,988 at risk
|
| Cardiogenic shock | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00010 events10 affected6,996 at risk
- EG0019 events9 affected6,958 at risk
- EG0025 events4 affected6,988 at risk
|
| Cardiomyopathy | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cardiopulmonary failure | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cardiovascular insufficiency | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Conduction disorder | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cor pulmonale chronic | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Coronary artery occlusion | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Coronary artery stenosis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Coronary artery thrombosis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Dressler's syndrome | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gastrocardiac syndrome | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Heart valve incompetence | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intracardiac thrombus | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ischaemic cardiomyopathy | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0028 events8 affected6,988 at risk
|
| Left ventricular dysfunction | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Left ventricular failure | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Low cardiac output syndrome | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Mitral valve calcification | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0018 events7 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Mitral valve prolapse | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Myocardial fibrosis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00011 events11 affected6,996 at risk
- EG0019 events9 affected6,958 at risk
- EG00210 events10 affected6,988 at risk
|
| Myocardial ischaemia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Myocardial oedema | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Myocardial rupture | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Myocarditis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Nodal arrhythmia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Nodal rhythm | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Palpitations | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pericardial haemorrhage | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pericarditis | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Pulseless electrical activity | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Right ventricular failure | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Sick sinus syndrome | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0008 events7 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0029 events8 affected6,988 at risk
|
| Sinoatrial block | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Sinus arrest | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Sinus arrhythmia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Sinus bradycardia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG00212 events12 affected6,988 at risk
|
| Sinus tachycardia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Subendocardial ischaemia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Supraventricular extrasystoles | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Systolic dysfunction | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Tachyarrhythmia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tachycardia paroxysmal | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ventricular arrhythmia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ventricular dysfunction | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ventricular extrasystoles | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0016 events4 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Ventricular fibrillation | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG0009 events9 affected6,996 at risk
- EG00111 events11 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Ventricular tachycardia | Cardiac disorders | MedDRA 17.0 | Systematic Assessment | | - EG00012 events12 affected6,996 at risk
- EG00120 events17 affected6,958 at risk
- EG00220 events17 affected6,988 at risk
|
| Atrial septal defect | Congenital, familial and genetic disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Acute vestibular syndrome | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Auricular perichondritis | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Deafness | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Deafness unilateral | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Inner ear disorder | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Meniere's disease | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Middle ear effusion | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Presbyacusis | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sudden hearing loss | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tympanic membrane perforation | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0008 events7 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0025 events4 affected6,988 at risk
|
| Vertigo labyrinthine | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vertigo positional | Ear and labyrinth disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0027 events6 affected6,988 at risk
|
| Autoimmune thyroiditis | Endocrine disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Goitre | Endocrine disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Hyperthyroidism | Endocrine disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypothyroidism | Endocrine disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Inappropriate antidiuretic hormone secretion | Endocrine disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Toxic nodular goitre | Endocrine disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Age-related macular degeneration | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Angle closure glaucoma | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Blindness unilateral | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cataract | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG00017 events14 affected6,996 at risk
- EG00118 events16 affected6,958 at risk
- EG00211 events10 affected6,988 at risk
|
| Cataract nuclear | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Conjunctival haemorrhage | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diabetic retinopathy | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Diplopia | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Endocrine ophthalmopathy | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Extraocular muscle paresis | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Eye haemorrhage | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Eyelid ptosis | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Glaucoma | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Macular degeneration | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Macular fibrosis | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Open angle glaucoma | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Opsoclonus myoclonus | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Optic ischaemic neuropathy | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pterygium | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Retinal artery embolism | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Retinal artery occlusion | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Retinal degeneration | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Retinal detachment | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events4 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Retinal haemorrhage | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Retinal vein occlusion | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Strabismus | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tolosa-Hunt syndrome | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vitreous haemorrhage | Eye disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Abdominal adhesions | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Abdominal hernia obstructive | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0016 events5 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Abdominal pain lower | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Abdominal wall haematoma | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Acute abdomen | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anal fissure | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anal fistula | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Anal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anal polyp | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anal stenosis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Appendiceal mucocoele | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ascites | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Barrett's oesophagus | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0017 events5 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Colitis ischaemic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Colitis ulcerative | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0029 events9 affected6,988 at risk
|
| Crohn's disease | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0024 events1 affected6,988 at risk
|
| Dental caries | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diaphragmatic hernia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Dieulafoy's vascular malformation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Diverticular perforation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Diverticulitis intestinal haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events4 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0029 events8 affected6,988 at risk
|
| Diverticulum intestinal | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Diverticulum intestinal haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG00115 events12 affected6,958 at risk
- EG00212 events11 affected6,988 at risk
|
| Duodenal stenosis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Duodenal ulcer | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Duodenal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Duodenitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Enteritis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Enterocolitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Enterocolitis haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Enterovesical fistula | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Erosive duodenitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Erosive oesophagitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Faecalith | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Femoral hernia, obstructive | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Food poisoning | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastric haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gastric perforation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastric polyps | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0017 events6 affected6,958 at risk
- EG00214 events13 affected6,988 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG00114 events14 affected6,958 at risk
- EG00218 events18 affected6,988 at risk
|
| Gastric ulcer perforation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG00011 events10 affected6,996 at risk
- EG0019 events8 affected6,958 at risk
- EG00218 events17 affected6,988 at risk
|
| Gastritis atrophic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Gastritis erosive | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Gastritis haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Gastritis hypertrophic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastroduodenitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gastroduodenitis haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal angiodysplasia haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Gastrointestinal erosion | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0009 events8 affected6,996 at risk
- EG00115 events15 affected6,958 at risk
- EG00227 events26 affected6,988 at risk
|
| Gastrointestinal mucosal disorder | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal necrosis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal pain | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Gastrointestinal perforation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal polyp haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gastrointestinal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Gastrointestinal vascular malformation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG00011 events10 affected6,996 at risk
- EG0017 events6 affected6,958 at risk
- EG00211 events11 affected6,988 at risk
|
| Gingival bleeding | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Haematochezia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Haemorrhagic erosive gastritis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0015 events4 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Ileus paralytic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Impaired gastric emptying | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG00212 events1 affected6,988 at risk
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG00022 events21 affected6,996 at risk
- EG00127 events26 affected6,958 at risk
- EG00225 events25 affected6,988 at risk
|
| Inguinal hernia strangulated | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Inguinal hernia, obstructive | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intestinal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intestinal infarction | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intestinal ischaemia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Intestinal perforation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intussusception | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Irritable bowel syndrome | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Large intestinal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Large intestine perforation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Large intestine polyp | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG00212 events12 affected6,988 at risk
|
| Lower gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Mallory-Weiss syndrome | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Mechanical ileus | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Melaena | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Mouth haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Oesophageal achalasia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oesophageal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oesophageal obstruction | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oesophageal pain | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Oesophageal rupture | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oesophageal stenosis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oesophageal ulcer | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oesophageal ulcer haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Oesophageal varices haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Oesophagitis haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pancreatic duct obstruction | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pancreatic fistula | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pancreatic mass | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0017 events6 affected6,958 at risk
- EG0028 events7 affected6,988 at risk
|
| Pancreatitis acute | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG00110 events10 affected6,958 at risk
- EG0028 events8 affected6,988 at risk
|
| Pancreatitis chronic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pancreatitis haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Papilla of Vater stenosis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Parotid gland inflammation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Peptic ulcer haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Peritoneal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Proctitis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Proctitis haemorrhagic | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Rectal polyp | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Reflux gastritis | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Small intestinal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Small intestinal perforation | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Thrombosis mesenteric vessel | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tongue blistering | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tooth disorder | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Toothache | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Umbilical hernia | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Umbilical hernia, obstructive | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Volvulus | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Volvulus of small bowel | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Asthenia | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0019 events7 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cardiac death | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Catheter site haemorrhage | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Chest discomfort | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Chest pain | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Death | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG00042 events42 affected6,996 at risk
- EG00134 events34 affected6,958 at risk
- EG00242 events42 affected6,988 at risk
|
| Device battery issue | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Device breakage | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Device defective | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Device dislocation | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Device lead damage | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Device lead issue | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Device malfunction | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Device material issue | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Device occlusion | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Drowning | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Drug withdrawal syndrome | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Euthanasia | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Fatigue | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gait disturbance | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| General physical health deterioration | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hernia obstructive | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypothermia | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Impaired healing | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Implant site pain | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Injection site bruising | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Malaise | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Medical device complication | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Multi-organ failure | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG000118 events109 affected6,996 at risk
- EG001124 events113 affected6,958 at risk
- EG002122 events115 affected6,988 at risk
|
| Oedema peripheral | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pain | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pyrexia | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Stent-graft endoleak | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sudden cardiac death | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG00033 events33 affected6,996 at risk
- EG00127 events27 affected6,958 at risk
- EG00227 events27 affected6,988 at risk
|
| Sudden death | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0009 events9 affected6,996 at risk
- EG00111 events11 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Systemic inflammatory response syndrome | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vessel puncture site haemorrhage | General disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Acute hepatic failure | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bile duct stenosis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG00010 events8 affected6,996 at risk
- EG0018 events7 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Biliary colic | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Biliary dyskinesia | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Biliary fistula | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Biloma | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Cholangitis sclerosing | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG00117 events17 affected6,958 at risk
- EG00210 events10 affected6,988 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG00011 events11 affected6,996 at risk
- EG00113 events11 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG00031 events31 affected6,996 at risk
- EG00118 events18 affected6,958 at risk
- EG00215 events15 affected6,988 at risk
|
| Cholestasis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Chronic hepatitis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cirrhosis alcoholic | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Drug-induced liver injury | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gallbladder disorder | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hepatic failure | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hepatic vein thrombosis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hepatomegaly | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hepatorenal failure | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hydrocholecystis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hyperplastic cholecystopathy | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Jaundice | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Jaundice cholestatic | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Liver disorder | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Non-alcoholic steatohepatitis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Portal vein thrombosis | Hepatobiliary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Allergy to arthropod sting | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anaphylactic reaction | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anaphylactic shock | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Anti-neutrophil cytoplasmic antibody positive vasculitis | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Contrast media allergy | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypersensitivity | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Reaction to food additive | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sarcoidosis | Immune system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Abdominal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Abdominal sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Abdominal wall abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Abdominal wall infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Abscess limb | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Abscess neck | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Acquired immunodeficiency syndrome | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Acute sinusitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Amoebiasis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Appendicitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0009 events9 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Appendicitis perforated | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Arthritis infective | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Atypical pneumonia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Avian influenza | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bacteraemia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bacterial infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Bacterial prostatitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bacterial pyelonephritis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bartholin's abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Biliary sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Breast abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bronchitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00020 events19 affected6,996 at risk
- EG00114 events10 affected6,958 at risk
- EG00227 events22 affected6,988 at risk
|
| Bronchitis bacterial | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchopneumonia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG00212 events12 affected6,988 at risk
|
| Bronchopulmonary aspergillosis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bursitis infective | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Campylobacter gastroenteritis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cellulitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00015 events14 affected6,996 at risk
- EG00119 events17 affected6,958 at risk
- EG00213 events12 affected6,988 at risk
|
| Cellulitis laryngeal | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cellulitis of male external genital organ | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cerebral toxoplasmosis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Chest wall abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cholangitis suppurative | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cholecystitis infective | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Chronic sinusitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Clostridium colitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Clostridium difficile colitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Clostridium difficile infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Clostridium difficile sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Colonic abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Congo-Crimean haemorrhagic fever | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cystitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Dengue fever | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Device related infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0015 events4 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Device related sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Diabetic foot infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diabetic gangrene | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Diverticulitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00012 events12 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG00212 events11 affected6,988 at risk
|
| Ear infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Emphysematous cholecystitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Encephalitis brain stem | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Endocarditis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Endocarditis bacterial | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Enteritis infectious | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Enterococcal sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Enterocolitis infectious | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Epididymitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Epiglottitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Erysipelas | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0025 events4 affected6,988 at risk
|
| Escherichia bacteraemia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Escherichia pyelonephritis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Escherichia sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Escherichia urinary tract infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Extradural abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Eye infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Furuncle | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gangrene | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0018 events5 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Gastritis viral | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00018 events18 affected6,996 at risk
- EG00116 events15 affected6,958 at risk
- EG00218 events18 affected6,988 at risk
|
| Gastroenteritis bacterial | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Gastroenteritis norovirus | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gastroenteritis rotavirus | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastroenteritis salmonella | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastroenteritis viral | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Gastrointestinal infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gingivitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Groin abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Groin infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| H1N1 influenza | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Haematoma infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Helicobacter gastritis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Helicobacter infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hepatitis A | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hepatitis viral | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Herpes simplex meningoencephalitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Herpes zoster | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Incision site infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Infected dermal cyst | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Infected fistula | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Infected skin ulcer | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Infectious colitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Infectious pleural effusion | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Infective exacerbation of chronic obstructive airways disease | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0014 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Influenza | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Intervertebral discitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Klebsiella sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Labyrinthitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Laryngitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Leishmaniasis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Listeria sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Liver abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Lobar pneumonia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Localised infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Lower respiratory tract infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0017 events6 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Lower respiratory tract infection bacterial | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lung abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lung infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lyme disease | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Malaria | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Meningitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Meningitis bacterial | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Muscle abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Myringitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Nasal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Nasopharyngitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Necrotising fasciitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Neutropenic sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ophthalmic herpes zoster | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Orchitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Osteomyelitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Otitis externa | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Otitis media acute | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Otitis media chronic | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pancreatic abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Paraspinal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Parotitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pelvic abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Periodontitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Perirectal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Peritonitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Peritonsillar abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pharyngeal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pilonidal cyst | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pneumococcal sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumocystis jirovecii pneumonia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumonia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00083 events76 affected6,996 at risk
- EG00172 events69 affected6,958 at risk
- EG00286 events77 affected6,988 at risk
|
| Pneumonia bacterial | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00012 events11 affected6,996 at risk
- EG00115 events15 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Pneumonia cytomegaloviral | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pneumonia haemophilus | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumonia influenzal | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pneumonia legionella | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumonia necrotising | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumonia pneumococcal | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pneumonia pseudomonal | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumonia streptococcal | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumonia viral | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Post procedural infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Post procedural pneumonia | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0019 events8 affected6,958 at risk
- EG0023 events2 affected6,988 at risk
|
| Proctitis infectious | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pseudomembranous colitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pseudomonal sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pseudomonas infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pulmonary sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pulmonary tuberculosis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Pyopneumothorax | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Rectal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Respiratory tract infection viral | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Retroperitoneal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Rhinitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Salmonellosis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Scrotal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00016 events15 affected6,996 at risk
- EG00120 events20 affected6,958 at risk
- EG00218 events17 affected6,988 at risk
|
| Septic necrosis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Septic shock | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG00212 events12 affected6,988 at risk
|
| Sialoadenitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sinusitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Skin infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Soft tissue infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Staphylococcal sepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Streptococcal abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Streptococcal infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Subacute endocarditis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Subcutaneous abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tonsillitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Toxoplasmosis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tracheitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tracheobronchitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tuberculosis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urethritis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urinary bladder abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG00015 events15 affected6,996 at risk
- EG00130 events27 affected6,958 at risk
- EG00230 events28 affected6,988 at risk
|
| Urinary tract infection pseudomonal | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Urosepsis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG00219 events19 affected6,988 at risk
|
| Vestibular neuronitis | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Viral diarrhoea | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Viral infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Wound abscess | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Wound infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0027 events6 affected6,988 at risk
|
| Wound infection bacterial | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Wound infection staphylococcal | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Yersinia infection | Infections and infestations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Abdominal wound dehiscence | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Accidental overdose | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Acetabulum fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Alcohol poisoning | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anaemia postoperative | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anaesthetic complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anastomotic complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anastomotic stenosis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anastomotic ulcer haemorrhage | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG00111 events11 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Arterial injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Arterial restenosis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Arthropod sting | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Back injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bone contusion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bone fissure | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Brain contusion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Brain herniation | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Burns second degree | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Burns third degree | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Carbon monoxide poisoning | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Carotid artery restenosis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cervical vertebral fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Chemical peritonitis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Chest injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Clavicle fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Concussion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Craniocerebral injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cystitis radiation | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Extradural haematoma | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Face injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Facial bones fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG00011 events10 affected6,996 at risk
- EG00111 events11 affected6,958 at risk
- EG00211 events11 affected6,988 at risk
|
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Forearm fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Foreign body | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Fractured ischium | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gas poisoning | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal stoma complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Gun shot wound | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Haematuria traumatic | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0015 events4 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Heat exhaustion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Heat stroke | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Incisional hernia | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Incisional hernia, obstructive | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Inflammation of wound | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intestinal anastomosis complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Joint capsule rupture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0026 events5 affected6,988 at risk
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Ligament injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ligament rupture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ligament sprain | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Limb crushing injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Limb injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Limb traumatic amputation | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lip injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Meniscus injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Multiple fractures | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Multiple injuries | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Muscle rupture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Muscle strain | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neck injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Osteoradionecrosis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pancreatic leak | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Patella fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Peripheral arterial reocclusion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Peripheral artery restenosis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Periprosthetic fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pneumothorax traumatic | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Poisoning | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Post gastric surgery syndrome | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Post procedural complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Post procedural fistula | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Post procedural haematoma | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Post procedural haematuria | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0017 events6 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG00011 events10 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG00212 events11 affected6,988 at risk
|
| Post procedural persistent drain fluid | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Post-traumatic pain | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Postoperative ileus | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Postoperative respiratory failure | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Postoperative thoracic procedure complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Postoperative wound complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Postpericardiotomy syndrome | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0027 events6 affected6,988 at risk
|
| Procedural hypotension | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Procedural pain | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pubis fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Pulmonary contusion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Radial nerve injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Radiation dysphagia | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Radius fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Remnant gastritis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Renal haematoma | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0028 events8 affected6,988 at risk
|
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Scapula fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Seroma | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Skull fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Soft tissue injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG00010 events10 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Spinal cord injury cervical | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Splenic rupture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Subdural haemorrhage | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Suture related complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tendon injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0015 events4 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Thoracic vertebral fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tibia fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Toxicity to various agents | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Traumatic haematoma | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG00110 events10 affected6,958 at risk
- EG00214 events13 affected6,988 at risk
|
| Traumatic haemorrhage | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Traumatic haemothorax | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Traumatic intracranial haemorrhage | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG00013 events11 affected6,996 at risk
- EG00119 events17 affected6,958 at risk
- EG00220 events18 affected6,988 at risk
|
| Traumatic spinal cord compression | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ulna fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Urinary retention postoperative | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urinary tract injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| VIIIth nerve injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vascular graft complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vascular graft occlusion | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vascular graft thrombosis | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vascular injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vascular procedure complication | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Venous injury | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Wound | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Wound haemorrhage | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Wrist fracture | Injury, poisoning and procedural complications | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Blood electrolytes decreased | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Blood glucose decreased | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Blood pressure increased | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Blood urine present | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cardiac stress test abnormal | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Clostridium test positive | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Ejection fraction decreased | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Electrocardiogram abnormal | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Glycosylated haemoglobin increased | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Haematocrit decreased | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Liver function test abnormal | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lymph node palpable | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Occult blood positive | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Scan myocardial perfusion abnormal | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Weight increased | Investigations | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Abnormal loss of weight | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Decreased appetite | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0019 events9 affected6,958 at risk
- EG00213 events11 affected6,988 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG00015 events13 affected6,996 at risk
- EG00115 events15 affected6,958 at risk
- EG00217 events15 affected6,988 at risk
|
| Diabetes mellitus inadequate control | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG00013 events13 affected6,996 at risk
- EG00113 events12 affected6,958 at risk
- EG00214 events11 affected6,988 at risk
|
| Diabetic complication | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Electrolyte imbalance | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Failure to thrive | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gout | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Hypocalcaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events5 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Hypovolaemia | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lactic acidosis | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lactose intolerance | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Malnutrition | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Obesity | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Type 1 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Type 2 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Ankylosing spondylitis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0009 events9 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG00210 events10 affected6,988 at risk
|
| Arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG00110 events8 affected6,958 at risk
- EG0028 events8 affected6,988 at risk
|
| Bone pain | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Chondrocalcinosis pyrophosphate | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Chondropathy | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Costochondritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Dupuytren's contracture | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Facet joint syndrome | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Fibromyalgia | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Foot deformity | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Fracture malunion | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Fracture nonunion | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gouty arthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events2 affected6,988 at risk
|
| Groin pain | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Haemarthrosis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hand deformity | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intervertebral disc compression | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Intervertebral disc disorder | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG00015 events14 affected6,996 at risk
- EG00110 events10 affected6,958 at risk
- EG00211 events8 affected6,988 at risk
|
| Jaw cyst | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Jaw disorder | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Joint ankylosis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Joint effusion | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lumbar spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Meniscal degeneration | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Mobility decreased | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Monarthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Muscle haemorrhage | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Muscle hypertrophy | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG00020 events20 affected6,996 at risk
- EG00123 events22 affected6,958 at risk
- EG00217 events16 affected6,988 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Myalgia intercostal | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Myopathy | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Myositis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG00062 events59 affected6,996 at risk
- EG00159 events54 affected6,958 at risk
- EG00257 events54 affected6,988 at risk
|
| Osteonecrosis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pain in jaw | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Periarthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Polyarthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Polymyalgia rheumatica | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Polymyositis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Psoriatic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Resorption bone increased | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Rhabdomyolysis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Rheumatoid arthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG00212 events12 affected6,988 at risk
|
| Sacroiliitis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events2 affected6,996 at risk
- EG0019 events9 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Spinal disorder | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0028 events7 affected6,988 at risk
|
| Spinal pain | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events2 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Spondylolisthesis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Spondylolysis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sympathetic posterior cervical syndrome | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Synovial cyst | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Systemic lupus erythematosus | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tendon calcification | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tendon disorder | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tendonitis | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Trigger finger | Musculoskeletal and connective tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Acinic cell carcinoma of salivary gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Acute myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0004 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Adenocarcinoma gastric | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Adenolymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Adrenal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ameloblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Anal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anaplastic large cell lymphoma T- and null-cell types | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anogenital warts | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Astrocytoma malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Atypical fibroxanthoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0009 events6 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG00212 events9 affected6,988 at risk
|
| Benign neoplasm of bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Benign neoplasm of ureter | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Benign ovarian tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Benign pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Benign renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Benign salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Benign soft tissue neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bile duct adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bile duct cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Biliary neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG00012 events11 affected6,996 at risk
- EG00115 events15 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Bladder cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0015 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Bladder papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bladder transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Bladder transitional cell carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bladder transitional cell carcinoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0003 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bone cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bone cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bone sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Brain cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Brain neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Brain neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Breast cancer female | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Breast cancer male | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0013 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Breast cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Brenner tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchioloalveolar carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cervix cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cervix carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cervix carcinoma stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cholangiocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cholesteatoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Choroid melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Chronic lymphocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0003 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Chronic myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Clear cell renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0014 events3 affected6,958 at risk
- EG0027 events7 affected6,988 at risk
|
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG00114 events14 affected6,958 at risk
- EG00214 events14 affected6,988 at risk
|
| Colon cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0029 events7 affected6,988 at risk
|
| Colon neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Colorectal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Colorectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Diffuse large B-cell lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0003 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Endometrial adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Endometrial cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Endometrial cancer stage I | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Epithelioid mesothelioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Essential thrombocythaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Fallopian tube cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Fibroma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Follicle centre lymphoma, follicular grade I, II, III stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Gallbladder adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gallbladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gallbladder cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastric adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0009 events8 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG00210 events8 affected6,988 at risk
|
| Gastrointestinal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal stromal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal stromal tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Gastrointestinal tract adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gastrooesophageal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Glioblastoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Glioblastoma multiforme | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Haemangioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hepatic cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hepatic cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Hepatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Hepatocellular carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hodgkin's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hypergammaglobulinaemia benign monoclonal | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Inflammatory pseudotumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Intestinal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Invasive ductal breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Large intestine benign neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Laryngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Laryngeal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Laryngeal squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Leiomyosarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lentigo maligna | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lip and/or oral cavity cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lip neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Lung adenocarcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG00010 events10 affected6,996 at risk
- EG00111 events11 affected6,958 at risk
- EG00214 events14 affected6,988 at risk
|
| Lung carcinoma cell type unspecified recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lung carcinoma cell type unspecified stage I | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lung carcinoma cell type unspecified stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG00010 events10 affected6,996 at risk
- EG00110 events10 affected6,958 at risk
- EG00217 events17 affected6,988 at risk
|
| Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Lymphoma cutis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lymphoplasmacytoid lymphoma/immunocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Malignant anorectal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Malignant ascites | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Malignant fibrous histiocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG00012 events10 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Malignant neoplasm of ampulla of Vater | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Malignant neoplasm of unknown primary site | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Malignant peritoneal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Malignant pleural effusion | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Mediastinum neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Melanocytic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Meningioma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metastases to central nervous system | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Metastases to liver | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metastases to lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Metastases to lymph nodes | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metastases to pancreas | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Metastases to peritoneum | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metastatic bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0004 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Metastatic carcinoma of the bladder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metastatic gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Metastatic malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metastatic pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metastatic salivary gland cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Metastatic squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Monoclonal gammopathy | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Myelofibrosis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Myeloproliferative disorder | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Nasal neoplasm benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neoplasm prostate | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neoplasm skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Neuroendocrine carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neuroendocrine carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Neuroendocrine tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Non-Hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Non-Hodgkin's lymphoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Non-Hodgkin's lymphoma stage I | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Non-Hodgkin's lymphoma stage II | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Non-Hodgkin's lymphoma unspecified histology aggressive | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Non-small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Non-small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oesophageal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Oesophageal adenocarcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Oesophageal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0026 events5 affected6,988 at risk
|
| Oncocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Oral cavity cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Oropharyngeal cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ovarian cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ovarian cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ovarian cancer stage III | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ovarian germ cell teratoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pancoast's tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0027 events6 affected6,988 at risk
|
| Pancreatic carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0007 events6 affected6,996 at risk
- EG0015 events4 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Paranasal sinus neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Parathyroid tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pelvic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Penile squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Penis carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Peritoneal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pharyngeal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pituitary tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Plasma cell myeloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pleomorphic adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pleural mesothelioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pleural mesothelioma malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Polycythaemia vera | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG00037 events37 affected6,996 at risk
- EG00129 events29 affected6,958 at risk
- EG00238 events38 affected6,988 at risk
|
| Prostate cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0028 events8 affected6,988 at risk
|
| Prostate cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Prostate cancer stage II | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Prostatic adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Rectal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Rectal adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Rectal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Rectosigmoid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Renal cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Renal cell carcinoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Renal oncocytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Salivary gland adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Salivary gland cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Salivary gland cancer recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Sarcoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Sarcomatoid mesothelioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Skin cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0005 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Small intestine carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Spinal cord neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Splenic marginal zone lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Squamous cell carcinoma of lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Squamous cell carcinoma of pharynx | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Squamous cell carcinoma of skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Thyroid adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Thyroid cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Thyroid neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tongue cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tongue neoplasm malignant stage unspecified | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tonsil cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tonsillar neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0004 events3 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Transitional cell carcinoma metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tumour associated fever | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tumour haemorrhage | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tumour pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Undifferentiated nasopharyngeal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ureteric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urethral cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Urinary tract neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Amyotrophic lateral sclerosis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Brain injury | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Brain oedema | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Brain stem infarction | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Brain stem syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Carotid arteriosclerosis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Carotid artery aneurysm | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Carotid artery disease | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG00217 events15 affected6,988 at risk
|
| Carotid sinus syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Carpal tunnel syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cauda equina syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Central nervous system lesion | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cerebellar ataxia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cerebral arteriosclerosis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cerebral cyst | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cerebral infarction | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cerebral ischaemia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cerebral microangiopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cerebrospinal fluid leakage | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Cerebrovascular disorder | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cervical cord compression | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cervical myelopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cervical radiculopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cervicobrachial syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cluster headache | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Cognitive disorder | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Complex regional pain syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Convulsion | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Dementia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Dementia Alzheimer's type | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Demyelinating polyneuropathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diabetic neuropathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Dizziness | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG00210 events9 affected6,988 at risk
|
| Encephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Epilepsy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0026 events5 affected6,988 at risk
|
| Extrapyramidal disorder | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Grand mal convulsion | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Guillain-Barre syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Haemorrhage intracranial | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Haemorrhagic stroke | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG00010 events10 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Haemorrhagic transformation stroke | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Headache | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Hypercapnic coma | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypertensive encephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hypoxic-ischaemic encephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| IIIrd nerve paralysis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intracranial aneurysm | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Intraventricular haemorrhage | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ischaemic cerebral infarction | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG00019 events18 affected6,996 at risk
- EG00111 events11 affected6,958 at risk
- EG00211 events11 affected6,988 at risk
|
| Leukoencephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Loss of consciousness | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Metabolic encephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Migraine | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Mononeuritis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Monoparesis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Multiple sclerosis relapse | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Muscle contractions involuntary | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Myelopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Myoclonus | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Nerve root compression | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neuralgia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Neuritis cranial | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Normal pressure hydrocephalus | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Occipital neuralgia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Orthostatic intolerance | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Parkinson's disease | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Parkinsonism | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Peripheral nerve paresis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Polyneuropathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Presyncope | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Psychomotor hyperactivity | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Quadriparesis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Radiculopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ruptured cerebral aneurysm | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sciatica | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events3 affected6,988 at risk
|
| Senile dementia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Serotonin syndrome | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Somnolence | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Spinal claudication | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events2 affected6,988 at risk
|
| Spinal cord compression | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Status epilepticus | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Subarachnoid haemorrhage | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Syncope | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG00030 events28 affected6,996 at risk
- EG00133 events31 affected6,958 at risk
- EG00239 events37 affected6,988 at risk
|
| Temporal lobe epilepsy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tension headache | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Toxic encephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Transient global amnesia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Trigeminal neuralgia | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Uraemic encephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| VIIth nerve paralysis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| VIth nerve paresis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vagus nerve disorder | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vascular encephalopathy | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vascular parkinsonism | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vertebral artery stenosis | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vertebrobasilar insufficiency | Nervous system disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Affective disorder | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Alcohol abuse | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Alcoholism | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Anxiety | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events2 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bipolar I disorder | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Confusional state | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Conversion disorder | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Delirium | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Depressed mood | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Depression | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG00011 events8 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG00213 events11 affected6,988 at risk
|
| Insomnia | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Major depression | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Panic attack | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Panic disorder | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Post-traumatic stress disorder | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Psychiatric decompensation | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Psychiatric symptom | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Psychotic behaviour | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Somatoform disorder cardiovascular | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Suicidal ideation | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Suicide attempt | Psychiatric disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Acute prerenal failure | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bladder diverticulum | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Bladder neck sclerosis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bladder prolapse | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bladder tamponade | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Calculus bladder | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Calculus ureteric | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Calculus urethral | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Calculus urinary | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cystitis haemorrhagic | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cystitis noninfective | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diabetic nephropathy | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Glomerulonephritis membranoproliferative | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Glomerulonephritis membranous | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG00111 events8 affected6,958 at risk
- EG0029 events9 affected6,988 at risk
|
| Haemorrhage urinary tract | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Hydronephrosis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Hypertensive nephropathy | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Nephritis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG00012 events8 affected6,996 at risk
- EG00111 events10 affected6,958 at risk
- EG00222 events21 affected6,988 at risk
|
| Neurogenic bladder | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Obstructive uropathy | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pelvi-ureteric obstruction | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Renal artery stenosis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Renal colic | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Renal cyst ruptured | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG00018 events15 affected6,996 at risk
- EG0019 events8 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Renal failure acute | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG00034 events28 affected6,996 at risk
- EG00132 events32 affected6,958 at risk
- EG00234 events32 affected6,988 at risk
|
| Renal failure chronic | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events6 affected6,996 at risk
- EG0018 events7 affected6,958 at risk
- EG0026 events5 affected6,988 at risk
|
| Renal haemorrhage | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Renal tubular acidosis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Stress urinary incontinence | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Tubulointerstitial nephritis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ureteric rupture | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ureteric stenosis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Urethral stenosis | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Urinary bladder haemorrhage | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urinary bladder polyp | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urinary incontinence | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Urinary tract disorder | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Urinoma | Renal and urinary disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Acquired hydrocele | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events4 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Acquired phimosis | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG00026 events26 affected6,996 at risk
- EG00126 events25 affected6,958 at risk
- EG00220 events20 affected6,988 at risk
|
| Breast fibrosis | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Calculus prostatic | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cervical cyst | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cervical dysplasia | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cystocele | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Endometrial hyperplasia | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Gynaecomastia | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Menorrhagia | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Metrorrhagia | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Ovarian necrosis | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Postmenopausal haemorrhage | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Prostatic mass | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Prostatism | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Prostatitis | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Prostatomegaly | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Uterine cyst | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Uterine haemorrhage | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Uterine polyp | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Uterine prolapse | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Uterovaginal prolapse | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vaginal prolapse | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Varicocele | Reproductive system and breast disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0023 events2 affected6,988 at risk
|
| Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0007 events7 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0027 events6 affected6,988 at risk
|
| Aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0006 events4 affected6,996 at risk
- EG0016 events6 affected6,958 at risk
- EG00212 events9 affected6,988 at risk
|
| Atelectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchial haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchial hyperreactivity | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchial obstruction | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchiectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Bronchospasm | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Choking | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG00065 events45 affected6,996 at risk
- EG00162 events39 affected6,958 at risk
- EG00274 events54 affected6,988 at risk
|
| Chronic respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diaphragmatic paralysis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Diffuse panbronchiolitis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG00012 events12 affected6,996 at risk
- EG00124 events23 affected6,958 at risk
- EG00230 events29 affected6,988 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Emphysema | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Epiglottic cyst | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Epiglottic oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG00117 events15 affected6,958 at risk
- EG00221 events20 affected6,988 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0026 events5 affected6,988 at risk
|
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hydrothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Laryngeal oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Lung consolidation | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lung disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Nasal septum deviation | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Nocturnal dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Obstructive airways disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Organising pneumonia | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pharyngeal haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events2 affected6,988 at risk
|
| Pharyngeal oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pleural adhesion | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG00018 events16 affected6,996 at risk
- EG0017 events6 affected6,958 at risk
- EG0023 events2 affected6,988 at risk
|
| Pleurisy | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Pleuritic pain | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0008 events6 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Pneumothorax spontaneous | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pulmonary arterial hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pulmonary congestion | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG00017 events17 affected6,996 at risk
- EG00117 events17 affected6,958 at risk
- EG00223 events21 affected6,988 at risk
|
| Pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Pulmonary haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Pulmonary mass | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events1 affected6,996 at risk
- EG0015 events5 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Respiratory arrest | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0017 events7 affected6,958 at risk
- EG0026 events6 affected6,988 at risk
|
| Respiratory tract haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Respiratory tract inflammation | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0023 events3 affected6,988 at risk
|
| Thoracic haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Tonsillar hypertrophy | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Vocal cord leukoplakia | Respiratory, thoracic and mediastinal disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Actinic keratosis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Angioedema | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0013 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Cutaneous sarcoidosis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Dermal cyst | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Dermatitis allergic | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Diabetic foot | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Drug eruption | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Dry gangrene | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Ecchymosis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hyperhidrosis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hyperkeratosis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypersensitivity vasculitis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Panniculitis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Psoriasis | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Pyoderma gangrenosum | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Rash generalised | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Skin haemorrhage | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Stevens-Johnson syndrome | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Accelerated hypertension | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Angiodysplasia | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00013 events13 affected6,996 at risk
- EG00119 events19 affected6,958 at risk
- EG00220 events19 affected6,988 at risk
|
| Aortic aneurysm rupture | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Aortic dissection | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Aortic dissection rupture | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Aortic rupture | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Aortic stenosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Aortic thrombosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Aorto-duodenal fistula | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Arterial rupture | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Arteriovenous fistula | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00010 events10 affected6,996 at risk
- EG0015 events4 affected6,958 at risk
- EG00211 events10 affected6,988 at risk
|
| Diabetic vascular disorder | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Essential hypertension | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Extremity necrosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Femoral artery aneurysm | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Femoral artery embolism | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Femoral artery occlusion | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hot flush | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hypertension | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00018 events18 affected6,996 at risk
- EG00115 events15 affected6,958 at risk
- EG0028 events8 affected6,988 at risk
|
| Hypertensive crisis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00014 events12 affected6,996 at risk
- EG0018 events8 affected6,958 at risk
- EG00211 events10 affected6,988 at risk
|
| Hypertensive emergency | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0015 events4 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Hypotension | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00010 events10 affected6,996 at risk
- EG0019 events9 affected6,958 at risk
- EG00210 events10 affected6,988 at risk
|
| Hypothenar hammer syndrome | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Hypovolaemic shock | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Iliac artery occlusion | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Intermittent claudication | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Leriche syndrome | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Lymphoedema | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Malignant hypertension | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0004 events4 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0025 events5 affected6,988 at risk
|
| Penetrating atherosclerotic ulcer | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00018 events15 affected6,996 at risk
- EG00110 events10 affected6,958 at risk
- EG00217 events17 affected6,988 at risk
|
| Peripheral artery aneurysm | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0003 events3 affected6,996 at risk
- EG0014 events4 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Peripheral artery stenosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00022 events17 affected6,996 at risk
- EG0017 events5 affected6,958 at risk
- EG0026 events5 affected6,988 at risk
|
| Peripheral artery thrombosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0005 events5 affected6,996 at risk
- EG0014 events3 affected6,958 at risk
- EG0024 events4 affected6,988 at risk
|
| Peripheral circulatory failure | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Peripheral embolism | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0022 events1 affected6,988 at risk
|
| Peripheral ischaemia | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG00013 events9 affected6,996 at risk
- EG0013 events3 affected6,958 at risk
- EG0026 events5 affected6,988 at risk
|
| Peripheral vascular disorder | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0008 events8 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0025 events4 affected6,988 at risk
|
| Poor peripheral circulation | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Shock | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Shock haemorrhagic | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Steal syndrome | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Subclavian artery occlusion | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Subclavian artery stenosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Superior vena cava syndrome | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Temporal arteritis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0012 events2 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Thrombosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events2 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Varicose vein | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0016 events5 affected6,958 at risk
- EG0022 events2 affected6,988 at risk
|
| Vasculitis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0000 events0 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Vena cava thrombosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0021 events1 affected6,988 at risk
|
| Venous insufficiency | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0002 events1 affected6,996 at risk
- EG0011 events1 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|
| Venous thrombosis | Vascular disorders | MedDRA 17.0 | Systematic Assessment | | - EG0001 events1 affected6,996 at risk
- EG0010 events0 affected6,958 at risk
- EG0020 events0 affected6,988 at risk
|